Investing Activities:
Purchases of short-term investments (350) (839)
Maturities of short-term investments 346 292
Purchases of machinery and equipment (326) (316)
Payments related to the purchase
of Cardiac Science, Inc. (194) (219)
Net cash flows used in
investing activities (524) (1,082)
Financing Activities:
Proceeds from exercise of stock options and
issuance of shares under employee purchase plan 173 255
Minimum tax withholding on restricted stock awards (141) (81)
Net cash flows provided by
financing activities 32 174
Net change in cash and cash equivalents 3,598 (880)
Cash and cash equivalents, beginning of period 16,561 10,699
Cash and cash equivalents, end of period $20,159 $9,819
Cardiac Science Corporation and Subsidiaries
Condensed Consolidated Statements of Cash Flows (unaudited)
(in thousands)
Twelve Months Ended
December 31
2007 2006
Operating Activities:
Net income $8,490 $49
Adjustments to reconcile net income to cash
provided by operatingactivities:
Licensing income and litigation settlement (6,000) -
Depreciation and amortization 6,746 6,261
Deferred income taxes 4,494 (781)
'/>"/>| SOURCE Cardiac Science Corporation Copyright©2008 PR Newswire. All rights reserved |